DPG Mitgliedschaft

This block is broken or missing. You may be missing content or you might need to enable the original module.

Keyword: immunotherapy

News

BioNTech Collaborations Move Beyond Vaccines

13.01.2022 -

Up to now, the name BioNTech has popped up mostly in one breath with Pfizer, the company’s US partner in developing the mRNA-based Covid-19 vaccine marketed as Comirnaty...

News

AstraZeneca and Transgene Link on Immunotherapy

08.05.2019 - Anglo-Swedish drugmaker AstraZeneca is to collaborate with French biotech Transgene, part of Institut Mérieux, to discover and develop immunotherapies for treating cancers and...

News

Eli Lilly and Nektar Develop Autoimmune Therapy

31.07.2017 - US pharma companies Eli Lilly and Nektar Therapeutics have signed an agreement to jointly develop the latter’s novel immunotherapy, NKTR-358, which could potentially treat a number...

News

US Merck Halts Trial Enrollment After Deaths

14.06.2017 - US pharmaceutical giant Merck has announced it is suspending new enrollments in two phase 3 multiple myeloma studies with its blockbuster immunotherapy drug Keytruda (pembrolizumab...

News

FDA Halts Cancer Trial After Deaths

14.07.2016 - The US Food and Drug Administration has ordered Juno Therapeutics to suspend its Phase II immunotherapy trials with adult patients suffering from relapsed or refractory B cell...

News

New Immunotherapy Coalition Launched in US

13.01.2016 - Five major internationally active drugmakers, including American biotech firms Amgen and Celgene, along with pharmaceutical giant Pfizer and non-US players such as Glaxo SmithKline...

News

Korean Drug Specialists Collaborate on Cancer Therapy

23.11.2015 - Singapore-based biotechnology firm Aslan Pharmaceuticals, which specializes in immunotherapy and targeted agents for cancer forms prevalent in Asia, has agreed to cooperate with...

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

Ehrenamtliches Engagement

This block is broken or missing. You may be missing content or you might need to enable the original module.

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!

Social Media

LinkedIn | Twitter

Subscribe to our Newsletter!

Newsletter

We keep you posted - Subscribe to the CHEManager International newsletter here!